Atea Pharmaceuticals, Inc.
AVIR· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Net Income | -$3.99M | -$2.19M |
| EPS Diluted | -$0.40 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atea Pharmaceuticals, Inc. · CIK 1593899 · Engraved from SEC EDGAR